Huh Hoyoung
SEC-identified person · CIK 1401267 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pliant Therapeutics, INC. PLRX | Director | filed 2020 - 2026 |
| Celsus Therapeutics Plc. CLTX | Director | filed 2024 - 2025 |
| Peak Bio, Inc. PKBO | Director | filed 2022 - 2024 |
| Eidos Therapeutics, Inc. EIDX | Director | filed 2018 - 2018 |
| Cytomx Therapeutics, Inc. CTMX | Director | filed 2015 - 2018 |
| Geron Corp GERN | Director · Executive Chairman | filed 2010 - 2018 |
| Rezolute, Inc. RZLT | Director · Chairman, Scientific Adv. Bd. | filed 2013 - 2017 |
| Facet Biotech Corp FACT | Director | filed 2009 - 2010 |
| Nektar Therapeutics NKTR | Director · Chief Operating Officer | filed 2007 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.